Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.98B | $3.35B | $3.58B | $3.78B | $3.98B | $4.34B | $4.58B |
| Cost of revenue | $2.45B | $2.73B | $2.93B | $3.09B | $3.23B | $3.54B | $3.72B |
| Gross profit | $530.0M | $619.9M | $652.0M | $684.1M | $749.0M | $798.0M | $858.0M |
| Gross margin | 17.8% | 18.5% | 18.2% | 18.1% | 18.8% | 18.4% | 18.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $103.8M | $123.8M | $135.3M | $137.1M | −$997.0M | −$69.0M | −$22.0M |
| EBITDA | $134.9M | $153.7M | $171.4M | $202.0M | −$794.0M | $213.0M | $179.0M |
| Net income | $60.3M | $70.3M | $64.4M | $100.9M | −$1.02B | −$19.0M | −$86.0M |
| Net margin | 2.0% | 2.1% | 1.8% | 2.7% | -25.6% | -0.4% | -1.9% |
| EPS (diluted) | 0.54 | 0.63 | 0.58 | 0.91 | -9.52 | -0.16 | -0.63 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds CVET.
No tracked institution reports a position in CVET as of their last filing.
No one on the platform has traded CVET yet.
| $2.9B |
| — |
| MORFMorphic Holding, Inc. | $56.99 | +0.04% | $2.9B | — |
| MYOVMyovant Sciences Ltd. | $26.98 | -0.04% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CVET Covetrus, Inc. (NASDAQ:CVET): Navigating the Animal Health Landscape with Precision https://beyondspx.com/article/covetrus-inc-nasdaq-cvet-navigating-the-animal-health-landscape-with-precision
View on StockTwits ↗$CVET Covetrus, Inc. (NASDAQ:CVET): Navigating the Animal Health Landscape with Precision http://beyondspx.com/2024/08/04/covetrus-inc-nasdaqcvet-navigating-the-animal-health-landscape-with-precision/
View on StockTwits ↗$CVET company-wide layoff today due to structural and strategic direction changes. Earlier this year, $CVET pleaded guilty to causing the introduction and delivery of veterinary prescription drugs that were misbranded into interstate commerce and has been sentenced to 1-year probation by a federal court in Abingdon, Virginia. As part of the agreement, Covetrus, based in Portland, Maine—must also pay more than $23M in criminal forfeitures and fines. https://www.mainebiz.biz/article/covetrus-lays-off-some-employees-in-restructuring
View on StockTwits ↗$CVET - Option Volatility signal: Covetrus pin risk is decreasing https://www.macroaxis.com/stock-options/CVET/Covetrus?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$CVET Covetrus Names Ajoy Karna as Chief Financial Officer https://www.stocktitan.net/news/CVET/covetrus-names-ajoy-karna-as-chief-financial-qhzd48klc8uj.html
View on StockTwits ↗$CVET New Press Release: Covetrus Names Ajoy Karna as Chief Financial Officer Covetrus®, a global leader in animal-health technology and services, today announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Foulston, who announced previously his retirement from the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221208005120/en/ Ajoy Karna, CFO, Covetrus (Photo: Business Wire) “Ajoy is a strategic and operational leader with deep global expertise in finance and driving companywide business growth,” said Benjamin Wolin, president and CEO of Covetrus. “He is a welcome addition to our leadership team, and Covetrus and our stakeholders wi (...) https://webchronicletoday.com?p=314920
View on StockTwits ↗$ELAN big news in animal health, stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html
View on StockTwits ↗$ABC stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This is going to help Covetrus take even more business from MWI which is going to hurt ABC. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html
View on StockTwits ↗$PDCO stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This is going to help Covetrus take even more business from Patterson. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html
View on StockTwits ↗$DXCM stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. ALRT is up and coming and will be launching an ultra low cost human CGM in 2024 that will put DXCM out of business. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html
View on StockTwits ↗$ABT stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This will hurt Libre 2 sales since veterinarians wont use it anymore. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html
View on StockTwits ↗$ZTS stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This will kill the AlphaTRAK 2 business. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html
View on StockTwits ↗lawsuit scanner for $CVET https://www.lawow.org/gatto-frances-vs-ellinger-deborah-g-et-al-2022-09-14
View on StockTwits ↗lawsuit scanner for $CVET https://www.lawow.org/pascual-v-covetrus-inc-2021-06-03/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.